Turenne Capital (Turenne Groupe) is a leading independent French small-cap private equity firm based in Paris, founded in 1999. It invests across venture capital, growth capital, and buyout capital, financing SMEs, startups, and mid-market companies throughout France.
Their most common stage is series-b (60% of deals).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Anne-Sophie MAES
Managing Partner of Nord Capital Partenaires
Antoine PUGET
Managing Partner
Damien GARAU
Managing Partner of Connect Pro
Mounia CHAOUI
Managing Partner – Health
Rémy GARELLO
Managing Partner of Connect Pro
Alexis DE MAISONNEUVE
Partner
Anne-Laure MEYNIER
Partner
Benjamin ALTARAS
Partner
Benjamin WAINSTAIN
Partner
Benoît PASTOUR
Partner
Frédéric HUMBERT
Partner
Jessica BARBÉ
Partner
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| CCoave Therapeutics | Series A | $32M | Jan 2025 |
| SSamanTree | Series B | — | Jan 2024 |
| DDomain Therapeutics | Series A | $42M | Jan 2022 |
 Germitec | Series B | — | — |
| AAViwest | Series B | — | — |
Top Co-Investors
Last updated: 8 September 2026